Action Wellbeing Digital Sciences - MEDI

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Premium

Dernier

0,01

Prix Achat

0,01

Prix Vente

0,01

Volume échangé

0,00 Fourchette du Jour 0,00

0,00 Plage de 52 semaines 0,00

Clôture Veille

0,01

Ouverture

Dernière Transaction

Dernière heure de transaction

Volume moyen (3 m)

Volume financier

VWAP

MedImmune, Inc. Announces Make-Whole Fundamental Change Relating to its 1.375% Convertible Senior Notes Due 2011 and 1.625% Conv

GAITHERSBURG, Md., June 18 /PRNewswire-FirstCall/ -- MedImmune, Inc. today announced that, in connection with the closing of the acquisition of...

MedImmune Wins Stevie(R) Award at 5th Annual American Business Awards(SM)

Biotechnology Company Honored for Internal Launch of Productivity Tracking System GAITHERSBURG, Md., June 12 /PRNewswire-FirstCall/...

MedImmune Receives Correspondence From FDA Regarding FluMist(R)

GAITHERSBURG, Md., May 25 /PRNewswire-FirstCall/ -- MedImmune, Inc. (NASDAQ:MEDI) announced today that the U.S. Food and Drug Administration...

Anti-Interleukin-9 Data Presented at the American Thoracic Society Meeting

PLYMOUTH MEETING, Penn., May 24 /PRNewswire-FirstCall/ -- Genaera Corporation (NASDAQ:GENR) today reported that MedImmune, Inc. (NASDAQ:MEDI...

FDA Advisory Committee Recommends Expanded Use of FluMist(R)

GAITHERSBURG, Md., May 16 /PRNewswire-FirstCall/ -- MedImmune, Inc. (NASDAQ:MEDI) today announced that the U.S. Food and Drug Administration's...

Data Show FluMist(R) May Reduce Seasonal Influenza Burden Among Children in School, Daycare Settings

New Economic Analyses of School and Daycare Study Outcomes Suggest Vaccinating Against Influenza May Produce Cost Savings for Community at Large...

MedImmune Announces Positive Clinical Results at PAS Annual Meeting From Large Prospective Trial in Prevention of Serious RSV Di

- Numax Achieves Primary Endpoint Among High-Risk Infants Versus Current Standard of Care and Shows Reduction of Medically Attended Outpatient...

MedImmune Provides Fellowship Grants To Six Pediatric Respiratory Researchers

- Archana Singh, M.D., Winthrop University Hospital, Receives $35,000 Grant - TORONTO, May 7 /PRNewswire-FirstCall/ -- Underscoring its...

MedImmune Provides Fellowship Grants To Six Pediatric Respiratory Researchers

- Victoria McMeen, M.D., University of Virginia, Receives $35,000 Grant - TORONTO, May 7 /PRNewswire-FirstCall/ -- Underscoring its commitment...

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	-0.24	-96	0.25	0.3	0.005	448706	0.02922244	CS
260	-1.76	-99.4350282486	1.77	1.94	0.005	288823	0.09013125	CS

MEDI - Frequently Asked Questions (FAQ)

What is the current Wellbeing Digital Sciences share price?

The current share price of Wellbeing Digital Sciences is $ 0,01

What is the 1 year trading range for Wellbeing Digital Sciences share price?

Wellbeing Digital Sciences has traded in the range of $ 0,00 to $ 0,00 during the past year

Volume
% Gagnants
% Perdants

Symbole	Prix	Vol.

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Wellbeing Digital Sciences Inc (MEDI)

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Statistiques et détails clés

MEDI Dernières nouvelles

MedImmune, Inc. Announces Make-Whole Fundamental Change Relating to its 1.375% Convertible Senior Notes Due 2011 and 1.625% Conv

MedImmune Wins Stevie(R) Award at 5th Annual American Business Awards(SM)

MedImmune Receives Correspondence From FDA Regarding FluMist(R)

Anti-Interleukin-9 Data Presented at the American Thoracic Society Meeting

FDA Advisory Committee Recommends Expanded Use of FluMist(R)

Data Show FluMist(R) May Reduce Seasonal Influenza Burden Among Children in School, Daycare Settings

MedImmune Announces Positive Clinical Results at PAS Annual Meeting From Large Prospective Trial in Prevention of Serious RSV Di

MedImmune Provides Fellowship Grants To Six Pediatric Respiratory Researchers

MedImmune Provides Fellowship Grants To Six Pediatric Respiratory Researchers

MEDI - Frequently Asked Questions (FAQ)

Moteurs

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Wellbeing Digital Sciences Inc (MEDI) Cours

Wellbeing Digital Sciences Inc (MEDI)

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Statistiques et détails clés

MEDI Dernières nouvelles

MedImmune, Inc. Announces Make-Whole Fundamental Change Relating to its 1.375% Convertible Senior Notes Due 2011 and 1.625% Conv

MedImmune Wins Stevie(R) Award at 5th Annual American Business Awards(SM)

MedImmune Receives Correspondence From FDA Regarding FluMist(R)

Anti-Interleukin-9 Data Presented at the American Thoracic Society Meeting

FDA Advisory Committee Recommends Expanded Use of FluMist(R)

Data Show FluMist(R) May Reduce Seasonal Influenza Burden Among Children in School, Daycare Settings

MedImmune Announces Positive Clinical Results at PAS Annual Meeting From Large Prospective Trial in Prevention of Serious RSV Di

MedImmune Provides Fellowship Grants To Six Pediatric Respiratory Researchers

MedImmune Provides Fellowship Grants To Six Pediatric Respiratory Researchers

MEDI - Frequently Asked Questions (FAQ)

Moteurs

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Supprimer les publicités